ACB Registers FIR In Chaudhary Brahm Prakash Ayurved Charak Sansthan Recruitment Fraud Case

New Delhi (PTI): The Anti-Corruption Branch has registered a case against the-then superintendent and other officials of Chaudhary Brahm Prakash Ayurved Charak Sansthan in Delhi’s Najafgarh for alleged irregularities in recruitment, officials said on Monday.

According to a complaint filed by Chaudhary Brahm Prakash Ayurved Charak Sansthan Director-Principal Prof Vidula Gujjarwar, it was alleged that Rajesh Tanwar — the-then office superintendent — had committed irregularities in recruitment and created fake and forged report for postgraduate courses, a senior Anti-Corruption Branch official said.
He committed serious irregularities by not following directions and not linking the recruitment files for postgraduate courses, they said.

A committee was constituted to inquire into the alleged irregularities committed in the recruitment for the posts of associate professor and assistant professor, they said.

According to the inquiry report, Tanwar committed serious irregularities by not following directions and not linking the recruitment files, the official said.

Multiple discrepancies such as manipulation and the creation of additional vacancies without following the norms were observed.

Two candidates — Alok Kumar Asthana and Mukesh Kumar Sharma — did not possess the qualification for the post and were declared not eligible by the first scrutiny committee, Joint Commissioner of Police (Anti-Corruption Branch) Madhur Verma said.

Subsequently, a second scrutiny committee made them eligible and shortlisted them for interview. Later, they were selected and allowed to join the department as associate professors, Verma said.

The inquiry committee submitted its report concluding that the allegations were found substantiated. Following recommendations from the competent authority, a case was registered on Friday under sections of the Indian Penal Code and the Prevention of Corruption Act and it is being investigated, he added.

Related Posts

  • Pharma
  • July 26, 2024
  • 110 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 105 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD